Select Page

ODEFSEY ® (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets, for oral use. Initial U.S. Approval: 2016

ODEFSEY ® (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets, for oral use. Initial U.S. Approval: 2016

ODEFSEY is a prescription medicine. ODEFSEY is used for HIV infection Treatment.
INDICATIONS AND USAGE
ODEFSEY is a three-drug combination of emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV nucleoside analog reversetranscriptase inhibitors (NRTIs), and rilpivirine (RPV), a non-nucleoside reverse transcriptase inhibitor (NNRTI), and is indicated as a complete regimen for the treatment of HIV-1 infection in patients 12 years of age and older as initial therapy in those with no antiretroviral treatment history with HIV-1 RNA less than or equal to 100,000 copies per mL; or to replace a stable antiretroviral regimen in those who are virologicallysuppressed (HIV-1 RNA less than 50 copies per mL) for at least six months with no history of treatment failure and no known substitutions associated with resistance to the individual components of ODEFSEY.
DOSAGE FORMS & STRENGTHS
Tablets: 200 mg of FTC, 25 mg of RPV and 25 mg of TAF.
Manufactured By: Gilead Sciences, Inc
Prescribing Information URL: Click Here

Procedure to buy ODEFSEY ® (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets?
To buy ODEFSEY ® (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets, patients can simply fill the order form or can send mail at info@bioniquehealthcare.com. or can also send Whatsapp message at +91 96677 50889. You will get reply within few hours with pricing and procedure details. Note:- the order will be confirmed only after the receipt of valid prescription of doctor.

Category:

Co-formulated rilpivirine, emtricitabine and tenofovir alafenamide (RPV/F/TAF) is the 6th single-tablet combination antiretroviral medication approved within the past decade for the treatment of HIV-1 infection. It was approved based on positive bioequivalence studies with already approved drugs with its component compounds, RPV and the single tablet regimen- elvitegravir, cobicistat, F/TAF.

Documentation

  1. Doctor’s Prescription – We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.
  2. Patient’s Medical history – We would require all test reports and medical reports of the patient for last 3 months.
  3. Patient’s Identity card – We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

For Overseas Patient

Can I get anti-cancer medicines even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. The Bionique Healthcare can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of –

ODEFSEY (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
ODEFSEY (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
ODEFSEY (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets in North America – Mexico.
ODEFSEY (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
ODEFSEY (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
ODEFSEY (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
ODEFSEY (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
ODEFSEY (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets in Australia and New Zealand.

For Indian Patient

Ani-Cancer ODEFSEY (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets are prescription drug. 

We facilitate by-

  • Helping in documentation to import the medicine for personal use.
  • Finding Genuine and reliable source in USA, Europe and Japan.
  • Ensuring 100% transparency.

ODEFSEY (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets can be shipped to Ahmedabad, Bangalore, Chennai, Cochin, Hyderabad, Delhi, Haryana, Jaipur, Jammu and Kashmir, Himachal Pradesh, Kolkata, Lucknow, Mumbai, Pune, Punjab and other cities in India. Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. 

Reviews

There are no reviews yet.

Be the first to review “ODEFSEY ® (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets, for oral use. Initial U.S. Approval: 2016”

Your email address will not be published. Required fields are marked *

Anti-Cancer Medicine Supplier.

Bionique Healthcare is a consulting pharmaceutical company which assist Patients in accessing medicines in India. Bionique Healthcare facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact Bionique at +91 9667750889 or write to at – info@bioniquehealthcare.com.

Product Disclaimer

Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturer or licensee. 

Bionique Healthcare does not lay any claim on them.